- Home
- CTXR vs GTIM Comparison
CTXR vs GTIM Comparison
Compare CTXR & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- GTIM
- Stock Information
- Founded
- CTXR 2007
- GTIM 1987
- Country
- CTXR United States
- GTIM United States
- Employees
- CTXR N/A
- GTIM N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- GTIM Restaurants
- Sector
- CTXR Health Care
- GTIM Consumer Discretionary
- Exchange
- CTXR Nasdaq
- GTIM Nasdaq
- Market Cap
- CTXR 28.4M
- GTIM 28.9M
- IPO Year
- CTXR N/A
- GTIM 1990
- Fundamental
- Price
- CTXR $3.30
- GTIM $2.54
- Analyst Decision
- CTXR Strong Buy
- GTIM
- Analyst Count
- CTXR 2
- GTIM 0
- Target Price
- CTXR $54.50
- GTIM N/A
- AVG Volume (30 Days)
- CTXR 185.5K
- GTIM 8.6K
- Earning Date
- CTXR 02-12-2025
- GTIM 01-29-2025
- Dividend Yield
- CTXR N/A
- GTIM N/A
- EPS Growth
- CTXR N/A
- GTIM N/A
- EPS
- CTXR N/A
- GTIM 0.14
- Revenue
- CTXR N/A
- GTIM $142,315,000.00
- Revenue This Year
- CTXR N/A
- GTIM N/A
- Revenue Next Year
- CTXR $216.25
- GTIM N/A
- P/E Ratio
- CTXR N/A
- GTIM $18.14
- Revenue Growth
- CTXR N/A
- GTIM 3.01
- 52 Week Low
- CTXR $2.44
- GTIM $2.18
- 52 Week High
- CTXR $26.75
- GTIM $3.45
- Technical
- Relative Strength Index (RSI)
- CTXR 41.54
- GTIM 50.64
- Support Level
- CTXR $3.70
- GTIM $2.52
- Resistance Level
- CTXR $4.43
- GTIM $2.54
- Average True Range (ATR)
- CTXR 0.54
- GTIM 0.07
- MACD
- CTXR 0.06
- GTIM 0.01
- Stochastic Oscillator
- CTXR 6.03
- GTIM 54.17
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; kids; breakfast; frozen custard; slides and drinks.